Skip to main content

Advertisement

Table 4 Changes in median expression and corresponding null probability values () for pair-wise comparison of disease classes and the non-fatigued control group for each individual gene in the CD19+ B cell Up-regulated gene set

From: Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood

  3-Class (NF Controls) 7-Class (Controls = LCA-0 U LCA-2)
Gene ISF CFS LCA-1 LCA-3 LCA-4 LCA-5 LCA-6
SP140 -0.03 (0.60) 0.02 (0.49) -0.07 (0.43) 0.10 (0.60) 0.01 (0.72) -0.08 (0.29) 0.07 (0.92)
CD22 -0.16 (0.10) -0.09 (0.31) -0.14 (0.17) -0.58 (0.02) -0.30 (0.04) 0.02 (0.35) 0.05 (0.70)
QRSL1 -0.03 (0.95) -0.21 (0.91) 0.29 (0.28) -0.10 (0.70) 0.23 (0.50) -0.16 (0.89) -0.49 (0.42)
PTPRK -0.12 (0.55) -0.21 (0.18) -0.12 (0.76) -0.07 (0.82) -0.22 (0.68) -0.20 (0.17) -0.07 (0.64)
P2RY10 0.01 (0.21) -0.02 (0.51) 0.08 (0.99) -0.08 (0.06) 0.28 (0.82) 0.11 (0.94) 0.20 (0.33)
TSPAN3 -0.10 (0.54) -0.20 (0.19) -0.24 (0.39) -0.17 (0.83) 0.13 (0.38) -0.08 (0.83) -0.02 (0.82)